Ovion Inc.
This article was originally published in Start Up
Executive Summary
Tubal ligation is an effective means of permanent birth control, but the procedure itself is no picnic. Ovion Inc. hopes to overcome the body's tendency to overgrow implanted objects, with a fiber-coated stent delivered non-surgically into the fallopian tubes.
You may also be interested in...
Permanent Contraception
Given the huge impact that having a baby has on every aspect of a woman's life--and that of her mate--it's small wonder that a growing number of companies are aiming to offer Baby Boomers improved contraceptive choices. Some are developing devices to make the widely performed tubal ligation surgery, which renders women sterile, less invasive, more convenient and safer than it has been to date. At least one firm hopes to give men a chance to participate in family planning via reversible vasectomization.
NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
Warning Letter Roundup & Recap – 19 January 2021
No device-related warning letters were released by the US FDA the week of 19 January.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: